With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t
Following a year of exceptional progress in IBD drug development, fierce competition in clinical trials for Chron’s Disease and Ulcerative Colitis remains high, and it’s time for biopharma to push
